 Ganglioside ratio index management melanoma report relevance ratio melanoma-associated ganglioside precursor management Stage II disease Tumor biopsy specimens melanoma patients ratio total lipid sialic acids LBSA melanoma ratio melanocytes progenitors melanoma LBSA tumor biopsy specimens Patients groups ratio LBSA tumor tissues Group Group II Group III overall survival patients onset Stage II disease different groups patients Group patients Group II Group III Interestingly Group III immunogenic gangliosides groups therapies gangliosides antigens results study ratio unusual well-defined biochemical criteria useful prognosis therapeutic management disease routine analysis ratio tumors surgery ratio feasible melanoma simple profile gangliosides forms cancer